MRI contrast agents: current status and future perspectives.
about
The Digital Fish Library: using MRI to digitize, database, and document the morphological diversity of fishNoninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approachesImaging and nanomedicine in inflammatory atherosclerosisRapid multislice T1 mapping of mouse myocardium: Application to quantification of manganese uptake in α-Dystrobrevin knockout miceFuture of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology.Manganese-based MRI contrast agents: past, present and future.Molecular imaging without radiopharmaceuticals?MRI contrast agents: basic chemistry and safety.MRI stem cell tracking for therapy in experimental cerebral ischemia.Gd loading by hypotonic swelling: an efficient and safe route for cellular labeling.Binary behaviour of an oxidation-responsive MRI nano contrast agent.Gold nanoparticles functionalised with fast water exchanging Gd3+ chelates: linker effects on the relaxivity.Magnetic Resonance Imaging of Human-Derived Amniotic Membrane Stem Cells Using PEGylated Superparamagnetic Iron Oxide Nanoparticles.On-bead combinatorial synthesis and imaging of europium(III)-based paraCEST agents aids in identification of chemical features that enhance CEST sensitivity.MRI in multiple sclerosis: current status and future prospectsIron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imagingNuclear microscopy: a novel technique for quantitative imaging of gadolinium distribution within tissue sections.Solid MRI contrast agents for long-term, quantitative in vivo oxygen sensing.Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer.Rapid T1 mapping of mouse myocardium with saturation recovery Look-Locker method.Revisiting an old friend: manganese-based MRI contrast agentsCharacterization of magnetic viral complexes for targeted delivery in oncology.Spatially resolved quantification of gadolinium(III)-based magnetic resonance agents in tissue by MALDI imaging mass spectrometry after in vivo MRI.Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRIROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies.Matrix-Assisted Ionization-Ion Mobility Spectrometry-Mass Spectrometry: Selective Analysis of a Europium-PEG Complex in a Crude Mixture.Magnetic Nanoparticles: Material Engineering and Emerging Applications in Lithography and Biomedicine.A Microfluidic Platform to design crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for enhanced MRIMicrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.Multifunctional imaging nanoprobesMagnetic quantum dots for multimodal imaging.The application of nanoparticles in gene therapy and magnetic resonance imaging.Glyconanotechnology.Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy.Comparison of divalent transition metal ion paraCEST MRI contrast agents.Contrast-enhanced cardiovascular magnetic resonance imaging of coronary vessel wall: state of art.Electron paramagnetic resonance: a powerful tool to support magnetic resonance imaging research.Difference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth.
P2860
Q24810358-B2EBB492-BD2B-4035-8B0D-B97A581D7C8FQ26822871-267AEFF8-651F-46BD-8141-69FA427C3062Q26865120-DFC5215D-4E0F-401D-AB96-C6ABF8EDA133Q27002916-E7D13895-ECE4-4CE0-977A-462C79A21F29Q28394445-0EA01B90-EDCC-498B-A7C0-2DC56A0E61EDQ30360777-32460922-85C0-4C70-88C5-3D66F223F7D5Q30461349-4E75C1C8-0DA4-40CD-8C46-18DF7CC4508DQ30487686-A3FA16C6-1BBF-468D-A013-B14E3EC593CDQ30574482-7F0F502A-2CFA-4A59-8BE0-48D4D94D095BQ30712193-CA4B957E-46CA-491B-9340-4A98E9C3F6F1Q30724674-7006314C-A221-43C1-8436-E0F5CBB48948Q30872930-63F2BC8D-86D4-467F-9AB8-046F6F0A16FDQ30885568-0CB120A4-643A-4818-84FA-60FB50CB0C50Q31127113-60B633AD-461F-4C53-B427-B23E704AA7C4Q31164046-05DA25A4-C21D-4B7A-8246-AD6380025C10Q33345057-D7C559C9-E582-47A1-9A5C-DA5025641F30Q33506902-212CB399-3321-4D7D-B8AE-5344A7574A7FQ33574781-16076252-16F0-40DC-8F45-A1566F3C2145Q33607091-93D9589E-99AE-49C4-A271-04880E5BF82CQ33693048-07A73DD0-047A-44F8-96F5-0D1D2E458F9EQ33894213-D2343624-10D7-4B5C-81CD-1491DE8F324AQ34217743-C357F6AF-98F3-4436-90EF-CB08B039E7C1Q35169228-0A08BF88-9173-4FD2-A45D-EA2A70E681F4Q35475901-D7A5E153-02F3-417E-A772-9E03FB2C34C7Q35562801-63841394-0758-41BD-89CA-45078141234AQ35609635-A5C4B047-BFFC-480E-B44A-D37382B08266Q35664458-801A8165-E14A-462D-9419-EBF98EAE0B5FQ35802348-60FFEBFB-9586-414D-AD77-07B5607D72FFQ36283461-32BAE41A-68A9-4AFD-867A-FA0872A3CD4BQ37453997-85F3B869-4165-4712-A452-58D595FEDC0CQ37605872-22C51B6B-47D0-400E-A99C-D23A309C6A3AQ37663915-6BEA2894-1DDD-455A-9A0B-91CCB895B83BQ37668366-A38173E2-145C-440C-ABEA-E5E7FE224EDAQ37864251-7AC08E85-362A-4EDC-B9E0-88F982076236Q38072859-CE11F129-D535-4B0A-852A-F3C5F3895E52Q38094012-5BF1E37E-E910-4868-861B-DCC7F5531CECQ38164202-4CC73D29-430C-4061-9BF3-80EE1BDE8245Q38177865-76D33B7E-813D-4107-81EA-4C79F7969499Q38264293-3D5685E9-B2C7-4DE1-B6E2-751DB9AEC823Q38376846-29464609-10B2-4A6E-8C5A-076CD75BACE7
P2860
MRI contrast agents: current status and future perspectives.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
MRI contrast agents: current status and future perspectives.
@ast
MRI contrast agents: current status and future perspectives.
@en
type
label
MRI contrast agents: current status and future perspectives.
@ast
MRI contrast agents: current status and future perspectives.
@en
prefLabel
MRI contrast agents: current status and future perspectives.
@ast
MRI contrast agents: current status and future perspectives.
@en
P1476
MRI contrast agents: current status and future perspectives
@en
P2093
Geralda A F van Tilborg
Gustav J Strijkers
P304
P356
10.2174/187152007780618135
P577
2007-05-01T00:00:00Z